300 related articles for article (PubMed ID: 18649679)
1. [Treatment of erectile dysfunction in patients with plastic induration of the penis].
Sokol'shchik MM; Gagarina SV; Petrovich RIu; Sadakova IV
Urologiia; 2008; (1):41-4. PubMed ID: 18649679
[TBL] [Abstract][Full Text] [Related]
2. Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: results from a prospective randomized trial.
Palmieri A; Imbimbo C; Creta M; Verze P; Fusco F; Mirone V
Int J Androl; 2012 Apr; 35(2):190-5. PubMed ID: 22085227
[TBL] [Abstract][Full Text] [Related]
3. Tadalafil and modifications in peak systolic velocity (Doppler spectrum dynamic analysis) in the cavernosal arteries of patients with type 2 diabetes after continuous tadalafil treatment.
La Vignera S; Calogero AE; Cannizzaro MA; Condorelli R; Noto Z; Vicari E
Minerva Endocrinol; 2006 Dec; 31(4):251-61. PubMed ID: 17213792
[TBL] [Abstract][Full Text] [Related]
4. Erectile dysfunction in aging male.
Romanelli F; Sansone A; Lenzi A
Acta Biomed; 2010; 81 Suppl 1():89-94. PubMed ID: 20518197
[TBL] [Abstract][Full Text] [Related]
5. Peyronie's disease with erectile dysfunction: penile modeling over inflatable penile prostheses.
Chaudhary M; Sheikh N; Asterling S; Ahmad I; Greene D
Urology; 2005 Apr; 65(4):760-4. PubMed ID: 15833523
[TBL] [Abstract][Full Text] [Related]
6. [Surgical treatment of erectile dysfunction in Peyronie's disease].
Tarasov NI; Bavil'skiĭ VF; Plaksin OF; Kondrat'ev LN
Urologiia; 2001; (6):35-40. PubMed ID: 11785080
[TBL] [Abstract][Full Text] [Related]
7. The evolving role of testosterone in the treatment of erectile dysfunction.
Shabsigh R; Rajfer J; Aversa A; Traish AM; Yassin A; Kalinchenko SY; Buvat J
Int J Clin Pract; 2006 Sep; 60(9):1087-92. PubMed ID: 16939550
[TBL] [Abstract][Full Text] [Related]
8. Transdermal and topical pharmacotherapy for male sexual dysfunction.
Ohebshalom M; Mulhall JP
Expert Opin Drug Deliv; 2005 Jan; 2(1):115-20. PubMed ID: 16296739
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of erectile dysfunction of neurogenic genesis with inhibitors of phosphodiesterase of type 5 in patients with diabetes mellitus].
Kurbatov DG; Rozhivanov RV
Urologiia; 2009; (5):48-9. PubMed ID: 20209871
[TBL] [Abstract][Full Text] [Related]
10. Is penile length a factor in treatment of erectile dysfunction with PDE-5 inhibitor?
Savas M; Yeni E; Ciftci H; Topal U; Utangac M; Verit A
J Androl; 2009; 30(5):515-9. PubMed ID: 19234311
[TBL] [Abstract][Full Text] [Related]
11. [Erectile dysfunction and obstructive sleep apnea syndrome].
Zhuravlev VN; Frank MA; Gomzhin AI
Urologiia; 2008; (2):35, 37-9. PubMed ID: 18572768
[TBL] [Abstract][Full Text] [Related]
12. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].
Kalinchenko SIu; Vorslov LO; Aglamazian NL; Morgunov LIu
Urologiia; 2007; (1):57, 59-61. PubMed ID: 17472002
[TBL] [Abstract][Full Text] [Related]
14. [Effects of different treatments on endothelial function in patients with erectile dysfunction and hypogonadism].
Mazo EB; Gamidov SI; Sotnikova EM
Ter Arkh; 2008; 80(12):59-63. PubMed ID: 19227909
[TBL] [Abstract][Full Text] [Related]
15. [Results of multidisciplinary assessment of patients with erectile dysfunction].
Gall H; Bähren W; Holzki G; Scherb W; Sparwasser C; Ziegler U
Hautarzt; 1990 Jul; 41(7):353-9. PubMed ID: 2401628
[TBL] [Abstract][Full Text] [Related]
16. Hormonal supplementation and erectile dysfunction.
Aversa A; Isidori AM; Greco EA; Giannetta E; Gianfrilli D; Spera E; Fabbri A
Eur Urol; 2004 May; 45(5):535-8. PubMed ID: 15082192
[TBL] [Abstract][Full Text] [Related]
17. [Neuroandrologic considerations in impotent patients with Peyronie's disease].
Salinas Casado J; Vírseda Chamorro M; Samblás García R; Esteban Fuertes M; Aristizábal Agudelo JM; Delgado Marín JA; Blázquez Izquierdo J; Resel Estévez L
Arch Esp Urol; 1997; 50(6):695-9. PubMed ID: 9412372
[TBL] [Abstract][Full Text] [Related]
18. [Sexual function rehabilitation of men with pituitary tumors].
Rozhivanov RV; Kurbatov DG
Urologiia; 2010; (4):48, 50-3. PubMed ID: 20973135
[TBL] [Abstract][Full Text] [Related]
19. Androgen deficiency in the etiology and treatment of erectile dysfunction.
Gore JL; Swerdloff RS; Rajfer J
Urol Clin North Am; 2005 Nov; 32(4):457-68, vi-vii. PubMed ID: 16291037
[TBL] [Abstract][Full Text] [Related]
20. Commentary on adjunctive use of testosterone gel with sildenafil for erectile dysfunction.
Morales A
J Urol; 2008 May; 179(5 Suppl):S103. PubMed ID: 18405738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
